Why gum disease is so common in people with Down syndrome, according to science

NEW YORK: Gum disease affects millions of people worldwide, but among individuals with Down syndrome, the burden is especially severe and often begins at a young age. Scientists may now be closer to understanding why. A new study published in the journal Cell Reports has uncovered biological changes that could help explain why people with Down syndrome develop gum disease far more frequently than the general population. The findings point to a combination of reduced saliva production, defects in calcium signaling and alterations in the oral microbiome that together may create the perfect conditions for oral disease. Researchers from the NYU College of Dentistry say the discoveries could eventually lead to therapies that improve not only oral health but also overall well-being for people living with Down syndrome. An overlooked oral health challenge Down syndrome is commonly associated with intellectual disabilities and increased risks of certain medical conditions, including hearing problems and congenital heart disease. Less widely recognised, however, is the significant burden of oral disease. Researchers noted that approximately 60 to 90 per cent of individuals with Down syndrome under the age of 35 develop gum disease, a prevalence that far exceeds rates seen in the general population and even among people with other intellectual disabilities. “Of the diverse health challenges that individuals with Down syndrome face, their higher risk of oral disease remains largely unexplored,” said Dr Ga-Yeon Son, senior research scientist in the Department of Molecular Pathobiology at NYU College of Dentistry and the study’s first author. Scientists say the findings suggest that oral health problems in Down syndrome cannot be explained solely by oral hygiene or dietary habits. The surprising role of saliva One of the study’s most significant findings centred on saliva. Studies increasingly show that many people with Down syndrome experience hyposalivation, a condition characterised by reduced saliva production. Although often overlooked, saliva plays an essential role in protecting oral tissues, neutralising acids, controlling harmful bacteria and helping prevent tooth decay and gum disease. To better understand what may be driving this problem, researchers studied a widely used mouse model of Down syndrome. The mice produced substantially less saliva than expected. Their saliva was also more acidic and contained elevated levels of certain immune markers linked to inflammation. The findings suggested that the problem may originate much deeper than previously understood. A tiny cellular defect with potentially major consequences Researchers discovered that a process known as store-operated calcium entry, a calcium signaling mechanism required for saliva secretion, was significantly impaired in the salivary glands. “This dysfunction in calcium signaling is likely responsible for hyposalivation in Down syndrome,” said Dr Rodrigo Lacruz, professor of molecular pathobiology at NYU College of Dentistry and the study’s senior author. According to the researchers, decreased saliva flow can trigger a cascade of consequences, disrupting the balance of microorganisms in the mouth and accelerating periodontal disease. Scientists found inflammation beyond the gums The study also identified increased inflammatory markers in gum tissue and reduced mitochondrial function in salivary glands. “These studies provide evidence of a pathway through which changes in mitochondrial function and calcium handling in salivary glands may be having a system-wide impact on the health of individuals with Down syndrome,” said Dr Beverly Rothermel, professor at UT Southwestern Medical Center and study co-author. Researchers say this finding is particularly important because oral health may influence much broader health outcomes. Why this matters beyond dentistry Gum disease is increasingly recognised as more than an oral health problem. Studies have linked chronic periodontal disease to a range of systemic conditions, including cardiovascular disease and cognitive decline. The researchers noted that this connection may be especially significant because people with Down syndrome already face an increased risk of developing Alzheimer’s disease as they age. Another unexpected clue In another surprising finding, researchers identified autoantibodies commonly used to diagnose Sjögren’s disease, an autoimmune disorder characterised by dry mouth and dry eyes. Additional testing suggested that individuals with Down syndrome may also face a higher risk of Sjögren’s disease, although researchers emphasised that further studies are needed to confirm the association. The mouth and gut may be working together Looking beyond the mouth, scientists also examined blood and gut microbiome samples. They found elevated levels of succinate, a metabolic byproduct increasingly associated with inflammation and periodontal disease. They also identified succinate-producing bacteria in both the gut and oral microbiome. “This systemic alteration of succinate and changes to the oral and gut microbiome appear to be influencing the biology of Down syndrome,” said Dr Deepak Saxena, professor of molecular pathobiology and director of research innovation and entrepreneurship at NYU College of Dentistry. Researchers believe these findings may offer important clues about why oral health problems in Down syndrome often appear particularly severe and persistent. Could an existing medicine help? The study also produced a potentially encouraging finding. Researchers tested pilocarpine, a medication commonly prescribed to stimulate saliva production in people with Sjögren’s disease and patients experiencing dry mouth after radiation treatment for head and neck cancers. The medication successfully increased saliva production in mice with Down syndrome. Scientists say therapies aimed at restoring saliva production could potentially improve dry mouth, reduce gum disease risk and even positively influence some of the broader health disturbances associated with Down syndrome. “Understanding the processes responsible for low saliva in Down syndrome and developing therapies to restore salivation could have a transformative impact on the oral and overall health of people with Down syndrome,” said Dr Lacruz. The researchers said their next focus will be determining whether improving saliva production can also help address some of the wider health challenges experienced by individuals with Down syndrome. Stay informed, stay alert! pk/03-Jul-2026/why-gum-disease-is-so-common-in-people-with-down-syndrome-according-to-science” target=”_blank” rel=”nofollow noopener noreferrer”>Read full story on Dental News